Results 21 to 30 of about 4,998,226 (295)

Towards Differentiated Rate Control for Congestion and Hotspot Avoidance in Implantable Wireless Body Area Networks

open access: yesIEEE Access, 2017
Implantable wireless body area networks (WBANs) are gaining considerable attention to the researchers due to their high potential in healthcare applications.
Muhammad Mostafa Monowar, Fuad Bajaber
doaj   +1 more source

QoE-Maximized Beam Assignment and Rate Control for Dynamic mm-Wave-Based Full-Duplex Small Cell Networks

open access: yesIEEE Open Journal of the Communications Society, 2023
This study investigates the resource management problem for millimeter-wave-based switched beam (SWB) full-duplex small cell networks with the consideration of user equipment’s (UE’s) quality of experience (QoE) requirement and time-varying
Chun-Hao Fang, Kai-Ten Feng
doaj   +1 more source

Strong Stationarity Conditions for Optimal Control Problems Governed by a Rate-Independent Evolution Variational Inequality

open access: yes, 2023
We prove strong stationarity conditions for optimal control problems that are governed by a prototypical rate-independent evolution variational inequality, i.e., first-order necessary optimality conditions in the form of a primal-dual multiplier system ...
Christof, Constantin   +3 more
core   +1 more source

Clinical Implications of Heart Rate Control in Heart Failure With Atrial Fibrillation: Multi-Center Prospective Observation Registry (CODE-AF Registry)

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundAtrial fibrillation (AF) is treated by heart rate (HR) control. However, the optimal HR target in AF patients with heart failure (HF) remains unclear.
Shinjeong Song   +16 more
doaj   +1 more source

STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION

open access: yesРоссийский кардиологический журнал, 2017
Pharmacological therapy remains the primary approach to atrial fibrillation (AF). Management of all AF patients includes the decision on rate or rhythm control. The latter means antiarrhythmic drugs application that are being selected primarily by safety
S. G. Kanorsky, Yu. S. Kovalenko
doaj   +1 more source

Rate Control [PDF]

open access: yesCirculation, 2006
The control of ventricular rate plays an important role in the management of patients with atrial fibrillation, decreasing symptoms and improving cardiac function, exercise capacity, and quality of life.1–3 Oral or intravenous agents are routinely administered to achieve adequate control of the ventricular rate by modulating atrioventricular nodal ...
openaire   +1 more source

Joint Design of Transmission Rate and Control for Wireless Sensor Networked Control Systems [PDF]

open access: yes, 2014
This paper is concerned with transmission rate and control codesign of wireless sensor networked control systems (WSNCS) with time-varying delay. Jointly designing transmission rate and control is an attractive paradigm for WSNCS, since the control ...
Peng Zeng   +9 more
core   +1 more source

GTFRC, a TCP friendly QoS-aware rate control for diffserv assured service [PDF]

open access: yes, 2006
This study addresses the end-to-end congestion control support over the DiffServ Assured Forwarding (AF) class. The resulting Assured Service (AS) provides a minimum level of throughput guarantee.
Dairaine, Laurent   +2 more
core   +1 more source

Atrial fibrillation: Yesterday, today, and tomorrow

open access: yesКубанский научный медицинский вестник
Background. Advances in electrophysiological research have led to a modern understanding of the mechanisms of atrial fibrillation — the most common sustained cardiac arrhythmia, which poses a risk of severe, often disabling, and fatal complications ...
S. G. Kanorskiy   +3 more
doaj   +1 more source

Prognostic impact of digoxin use for rate control of atrial fibrillation in patients ≥75 years of age

open access: yesMonaldi Archives for Chest Disease, 2018
Digoxin use remains a common therapeutic option in the pharmacological control of heart rate in patients with atrial fibrillation, endorsed in current guidelines with the same level of evidence than beta-blockers in patients with and without heart ...
Maria Teresa La Rovere, Egidio Traversi
doaj   +1 more source

Home - About - Disclaimer - Privacy